Search for: "Teva Pharmaceuticals" Results 821 - 840 of 1,429
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jun 2011, 2:25 am
The Bedford Report keeps an eye on healthcare companies and provides research reports on Teva Pharmaceutical Industries Limited (makers of generic Yasmin) and Mylan Inc., the makers of Effexor. [read post]
16 May 2012, 2:30 am
While Bayer is listed as the main defendant in her case, Atkinson is also naming generic drug makers Barr and Teva Pharmaceuticals. [read post]
25 Oct 2012, 7:22 am by Christopher Walsh
., of the District of New Jersey has stayed several class-action litigations challenging the legality of certain reverse-payment settlement agreements between Wyeth and generic drug manufacturer Teva Pharmaceuticals, pursuant to which Wyeth allegedly paid Teva to delay its marketing of a generic counterpart to Wyeth’s Effexor XR drug. [read post]
31 Oct 2011, 5:46 pm
Barr Laboratories, a division of Teva Pharmaceutical Industries, Ltd., filed an ANDA to manufacture a generic version of the brain cancer drug Temodar which is currently covered under a patent owned by Cancer Research Technology and licensed to Merck & Co. [read post]
24 Sep 2007, 7:01 am
The related patent covers a method of making gabapentin that is stable enough to work well for pharmaceutical use. [read post]
10 Oct 2008, 11:32 am
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) - US: Trial judge grants permanent injunction in case relating to recombinant erythropoietin (EPO) patent: Amgen v… [read post]
30 Oct 2014, 12:02 pm
“Some of the biggest generic drug companies — Mylan, Actavis and Teva Pharmaceutical Industries — have been aggressively snapping up other manufacturers in recent years,” Lazarus wrote, “reducing the number of players in the market. [read post]
22 Nov 2019, 6:59 am
  In the document, shots are fired at the pharmaceutical industry and the Labour Party's take on the patent system in a call-out box entitled "Patents and their impact on drug prices" (page 9) which reads:"This granting of market exclusivity is the largest public subsidy to the pharmaceutical industry. [read post]
27 Jul 2011, 4:06 pm by Lawrence B. Ebert
Caraco :Defendants-Appellees Caraco Pharmaceutical Labora- tories, Ltd. and Sun Pharmaceutical Industries, Ltd. [read post]
1 Apr 2007, 6:14 pm
The Federal Circuit Continues Its Capitulation on Declaratory Judgment Actions By Kevin E. [read post]
25 Jan 2017, 11:25 pm
However, claim 27 is to “a pharmaceutical composition comprising a compound according to any one of claims 1-25 together with a pharmaceutically acceptable carrier and optionally other therapeutic ingredients” (emphasis added). [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch)   [read post]
26 May 2007, 11:26 pm
Alza sued Madison- based Wyeth last year, saying the tablet infringes a patent covering a technology that allows a drug to be slowly released into the bloodstream.# AstraZeneca's Seroquel for acute mania associated with bipolar disorder is being challenged by Teva Pharmaceutical Indus tries. [read post]
1 Sep 2010, 6:49 am by FDABlog HPM
  (Apotex subsequently submitted an Emergency Petition for Stay of Action to FDA asking the Agency to strip Teva of its final ANDA aproval – once again based on the mistaken belief that Teva is not eligible for 180-day exclusivity. [read post]
19 Apr 2010, 1:34 pm by FDABlog HPM
District Court for the District of Delaware’s recent decision in Millennium Pharmaceuticals, Inc. v. [read post]
9 Jan 2023, 9:01 pm by renholding
Teva Pharmaceutical The $420 million settlement between Teva and investors resolves allegations that the company engaged in a generic drug price-fixing conspiracy that allowed it to drastically raise prices on generic drugs from 2013 to 2015 – as high as 1,000%. [read post]
25 May 2015, 4:15 am
.* Colourless Copaxone in the clear: Teva's synthesis patents held to be (mostly) validThe never-ending litigation between Synthon and Teva over Copaxone (glatiramer acetate) has already given us interesting and striking decisions from the Patents Court  [also here], the Court of Appeal in England, and also the US Supreme Court. [read post]
21 Mar 2008, 12:49 pm
In a long-running battle with Teva Pharmaceutical, Abbott has tried to stay one step ahead of the generic entry. [read post]